tiprankstipranks
Herbs Generation Group Holdings Limited Class H (HK:2593)
:2593
Hong Kong Market
Want to see HK:2593 full AI Analyst Report?

Herbs Generation Group Holdings Limited Class H (2593) AI Stock Analysis

1 Followers

Top Page

HK:2593

Herbs Generation Group Holdings Limited Class H

(2593)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - Gpt-5.6Sol)
Rating:50Neutral
Price Target:
HK$0.97
â–¼(-19.83% Downside)
Action:Reiterated
Date:08/19/26
The score is held down primarily by the 2025 financial reversal (loss-making results and sharply weaker cash generation), despite a relatively resilient balance sheet. Technicals are broadly neutral with price near short-term averages but below longer-term moving averages. Valuation support comes mainly from the high dividend yield, tempered by loss-making performance and negative free cash flow.
Positive Factors
Manageable Leverage
Low leverage and a sizable equity base provide financial resilience, reduce dependence on external funding, and give the company more flexibility to manage the current earnings downturn while pursuing operational recovery.
Negative Factors
Sharp Profitability Reversal
The move from profitability to a substantial net loss signals a material deterioration in operating economics. Sustained losses could weaken equity returns, constrain reinvestment, and make recovery dependent on reversing cost, pricing, or demand pressures.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Low leverage and a sizable equity base provide financial resilience, reduce dependence on external funding, and give the company more flexibility to manage the current earnings downturn while pursuing operational recovery.
Read all positive factors

Herbs Generation Group Holdings Limited Class H (2593) vs. iShares MSCI Hong Kong ETF (EWH)

Herbs Generation Group Holdings Limited Class H Business Overview & Revenue Model

Company Description
Herbs Generation Group Holdings Ltd. specializes in the formulation, distribution, and promotion of health supplements, cosmetic items, and skincare solutions. Its extensive portfolio encompasses brands like Herbs, ZINO, Classic, Umeya, Energie, R...

Herbs Generation Group Holdings Limited Class H Financial Statement Overview

Summary
Financial performance is weak due to a sharp 2025 deterioration: revenue fell ~7%, margins compressed, and the company swung from a ~5.3% net margin (2024) to a ~-10.1% loss. Cash flow also collapsed with near-breakeven operating cash flow and negative free cash flow (~-3.2M) versus strong positive FCF in 2021–2024. The balance sheet is a relative strength (low debt-to-equity ~0.15), but it does not offset the earnings and cash-generation reversal.
Income Statement
42
Neutral
Balance Sheet
73
Positive
Cash Flow
28
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue244.97M227.87M245.49M251.22M208.03M188.64M
Gross Profit155.19M134.87M161.06M170.35M149.59M135.80M
EBITDA22.22M-6.79M40.81M63.35M45.89M36.49M
Net Income-2.05M-23.01M12.96M39.50M27.97M23.18M
Balance Sheet
Total Assets209.06M194.13M242.00M141.05M124.11M114.07M
Cash, Cash Equivalents and Short-Term Investments89.75M78.22M119.22M22.48M12.93M4.20M
Total Debt26.73M22.23M32.22M28.98M28.24M33.82M
Total Liabilities49.41M49.96M54.82M50.42M54.02M62.46M
Stockholders Equity159.65M144.17M187.18M90.63M70.09M51.62M
Cash Flow
Free Cash Flow10.54M-3.16M31.96M32.67M30.52M20.72M
Operating Cash Flow13.09M154.00K37.43M37.38M32.72M24.90M
Investing Cash Flow-3.57M-3.32M-5.13M-4.51M2.74M-3.44M
Financing Cash Flow53.69M-37.83M64.43M-23.32M-26.02M-21.43M

Herbs Generation Group Holdings Limited Class H Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.21
Price Trends
50DMA
0.95
Negative
100DMA
0.99
Negative
200DMA
1.06
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
46.88
Neutral
STOCH
37.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2593, the sentiment is Negative. The current price of 1.21 is above the 20-day moving average (MA) of 0.95, above the 50-day MA of 0.95, and above the 200-day MA of 1.06, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.88 is Neutral, neither overbought nor oversold. The STOCH value of 37.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2593.

Herbs Generation Group Holdings Limited Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$9.08B11.2025.72%6.24%23.19%-22.44%
65
Neutral
HK$24.80B8.6510.98%7.52%2.19%10.78%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
HK$21.58B-232.32-1.21%4.20%-2.44%81.73%
50
Neutral
HK$128.00M-6.36-13.48%15.63%-9.95%-834.42%
46
Neutral
HK$910.96M-15.68-12.81%0.53%13.43%7.72%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2593
Herbs Generation Group Holdings Limited Class H
0.94
-0.31
-24.80%
HK:1044
Hengan International Group Co
21.32
-2.20
-9.33%
HK:0157
Natural Beauty Bio-Technology
0.45
-0.10
-18.18%
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
22.50
-70.35
-75.77%
HK:6993
Blue Moon Group Holdings Ltd.
3.81
0.65
20.57%
HK:1318
Mao Geping Cosmetics Co., Ltd. Class H
48.10
-50.94
-51.43%

Herbs Generation Group Holdings Limited Class H Corporate Events

Herbs Generation Schedules Board Meeting on 2026 Interim Results and Dividend
Aug 13, 2026
Herbs Generation Group Holdings Limited has scheduled a board meeting for 25 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The board will also consider whether to recommend the payment of an...
Herbs Generation flags sharply narrower loss on reduced marketing spend
Aug 12, 2026
Herbs Generation Group Holdings Limited has issued a profit alert indicating a significant reduction in net loss for the six months ended 30 June 2026, with expected losses narrowing to HK$3.5 million to HK$4.5 million from HK$7.5 million a year e...
Herbs Generation Details Board and Committee Structure
Aug 2, 2026
Herbs Generation Group Holdings Limited has outlined its current Board composition, confirming a mix of executive, non-executive and independent non-executive directors. The company reinforces a governance structure aligned with Hong Kong listing ...
Herbs Generation Executive Director Resigns to Focus on Subsidiary Operations
Jul 31, 2026
Herbs Generation Group Holdings Limited has announced the resignation of executive director Ms. Young Yuen Pik, effective 1 August 2026. She is stepping down from the board to concentrate on managing and operating the group’s business at the...
Herbs Generation Wins Unanimous Shareholder Backing for AGM Resolutions and Capital Mandates
Jun 22, 2026
Herbs Generation Group Holdings Limited reported that all ordinary resolutions at its 22 June 2026 annual general meeting were approved by shareholders, including adoption of the 2025 audited accounts and confirmation of board and auditor mandates...
Herbs Generation Reschedules AGM After Black Rainstorm Warning in Hong Kong
Jun 18, 2026
Herbs Generation Group Holdings Limited has postponed its annual general meeting originally set for the afternoon of 18 June 2026 in Kowloon after a black rainstorm warning disrupted local conditions. The AGM has been rescheduled to 2:00 p.m. on 2...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2026